Physician
Abbaspour INC.
Abbaspour INC. was paid $276K by Medicaid between Jan 2018 and Nov 2024, across 19 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoABBASPOUR INC.
INDIANAPOLIS, IN 46256
INDIANAPOLIS, IN 46256
33aNPI1821305012assigned 09/09/2010
33bProvider typeFamily Medicine Physician
28Total paid$276K
24GClaims8,381
24DCodes billed19
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Indiana
Rank by total paid#132 of 408
Median peer was paid$81K
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,177 | $12K | |
| 2019 | 1,251 | $35K | |
| 2020 | 1,305 | $44K | |
| 2021 | 2,314 | $72K | |
| 2022 | 831 | $23K | |
| 2023 | 561 | $25K | |
| 2024incomplete | 942 | $65K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 1,925 | 1,638 | $80K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 22% | 656 | 207 | $60K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.8% | 1,219 | 989 | $27K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.0% | 671 | 553 | $25K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 8.7% | 504 | 492 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.4% | 445 | 404 | $18K |
| 99417 | Prolong home eval add 15m | 4.3% | 132 | 38 | $12K |
| 80305 | 3.2% | 1,170 | 992 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 130 | 115 | $9K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 528 | 396 | $4K |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | <1% | 41 | 15 | $3K |
| 87428 | <1% | 39 | 37 | $2K |
7 more codes
| 99201 | <1% | 44 | $1K | |
| 81025 | <1% | 318 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 55 | $919.17 |
| 96127 | <1% | 276 | $573.54 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 116 | $333.52 |
| 36415 | Collection of venous blood by venipuncture | <1% | 92 | $135.05 |
| 86580 | <1% | 20 | $29.47 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABBASPOUR, HAMID (PRESIDENT)
Parent organizationABBASPOUR INC